The role of altered blood vessels in brain tumors

(Image: Pixabay CC0) In a recent research, scientists have revealed new insights into the complex network of blood vessels in brain metastases, which were not well understood before. They've emphasized a significant increase in a molecule called CD276, known for its role in immune regulation. What's promising is that experimental antibodies targeting CD276 have shown positive results in early trials, suggesting a potential breakthrough in treatment approaches. The research, conducted by Leire Bejarano and Johanna Joyce from the Lausanne Branch of the Ludwig Institute for Cancer Research, is published in Cancer Cell. The study sheds light on crucial aspects of brain metastasis and aims to unravel the intricacies of blood vessel structures within brain tumors, with the hope of revolutionizing treatment strategies. Scientists delved into the detailed network of blood vessels in human brain metastases, particularly those originating from aggressive tumors like lung, melanoma, and breast cancers. Using advanced techniques such as single-cell and bulk RNA-sequencing, they carefully examined the key components of blood vessels, specifically endothelial and mural cells.